.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
UBS
McKinsey
Chinese Patent Office
Fuji
Harvard Business School
Farmers Insurance
Deloitte
QuintilesIMS

Generated: November 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: tolazamide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan Pharms Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL070259ANDAMylan Pharmaceuticals Inc.0378-0217-01100 TABLET in 1 BOTTLE, PLASTIC (0378-0217-01)
Mylan Pharms Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL070259ANDAMylan Pharmaceuticals Inc.0378-0551-01100 TABLET in 1 BOTTLE, PLASTIC (0378-0551-01)
Mylan Pharms Inc
TOLAZAMIDE
tolazamide
TABLET;ORAL070259ANDAPD-Rx Pharmaceuticals, Inc.55289-265-9090 TABLET in 1 BOTTLE, PLASTIC (55289-265-90)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Julphar
Queensland Health
Chinese Patent Office
US Army
Chubb
Covington
Novartis
AstraZeneca

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot